Aspen Pharmacare Holdings Ltd - ADR
APNHY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.36B
Close$
$4.78
51.4% downside
Current Fair Value
51.4% downsideOvervalued by 51.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.36 Billion |
|---|---|
| Enterprise Value | $3.93 Billion |
| Annual dividend | $0.12 |
| Dividend yield | 1.47% |
| Earnings per Share | $5.79 |
| Beta | 0.4 |
| Outstanding Shares | 443,586,000 |
Return
| Return on Equity | 1.92% |
|---|---|
| Return on Assets | 1.43% |
| Return on Invested Capital | 6.48% |
Valuation & Multiples
| P/E Ratio | 26.51 |
|---|---|
| PEG | -19.64 |
| Price to Sales | 0.06 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 0.66 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 3.93 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 3, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $180▼ 2.17% |
| Investors Holding | 10% |
About Aspen Pharmacare Holdings Ltd
9,557 employees
CEO: Stephen Saad
Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities...